CF CF Industries

Q2 2025 10-Q
Filed: Aug 7, 2025Period ending Jun 30, 2025
Health Care
Agricultural ChemicalsSEC EDGAR

CF Industries (CF) 10-Q quarterly report for Q2 2025, filed with SEC EDGAR on Aug 7, 2025 for the fiscal period ending Jun 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q2 2025 10-Q

Management Discussion & Analysis

  • No revenue or profitability data provided in section
  • No segment or product line performance disclosed
+3 more insights

Risk Factors

  • New project risk: Completion and funding of low-carbon ammonia facility at Blue Point complex uncertain, capital expenditures may exceed estimates
  • Regulatory risk: Potential impacts of announced or future tariffs and retaliatory measures on capital project materials availability and pricing
+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$1.9B

+20.2% YoY +13.7% QoQ

Net Income

$386M

-8.1% YoY +23.7% QoQ

Gross Margin

39.9%

-325bp YoY +555bp QoQ

Operating Margin

34.3%

-630bp YoY +693bp QoQ

Net Margin

20.4%

-629bp YoY +166bp QoQ

EPS (Diluted)

$2.35

+3.1% YoY +27.0% QoQ

Operating Cash Flow

$563M

+18.5% YoY -3.9% QoQ

Source: XBRL data from CF Industries Q2 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other CF Industries Quarterly Reports

Get deeper insights on CF Industries

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.